beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-acylsphingosine

Term ID

CHEBI:17950

Synonyms

(2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl 4-O-beta-D-galactopyranosyl-beta-D-glucopyranoside
(Gal)1 (Glc)1 (Cer)1
a beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-Cer(d18:1(4E))
beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-Cer
beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide
beta-D-galactosyl-(1->4)-beta-D-glucosylceramides
beta-D-Galactosyl-1,4-beta-D-glucosylceramide
beta-D-galactosyl-1,4-beta-D-glucosylceramides
beta-D-Galp-(1->4)-beta-D-Glc-(1<->)-Cer
beta-lactosylceramide
D-Galactosyl-1,4-beta-D-glucosylceramide
Gal-beta1->4Glc-beta1->1'Cer
Galbeta1-4Glcbeta-Cer
LacCer
Lactosyl-N-acylsphingosine
Lactosylceramide
lactosylceramides
N-[(2S,3R,4E)-1-{[beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
N-lignoceroyl-1-sphingosyl lactoside

(all 19)

Definition

A diosylceramide having beta-D-galactosyl-(1->4)-beta-D-glucose as the disaccharide component.

References

(all 31)

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-acylsphingosine

Phenotype where environments contain beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-acylsphingosine

Phenotype modified by environments containing beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-acylsphingosine

Phenotype affecting beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-acylsphingosine

Human Disease Model